Search Results - "Ala‐Opas, M."

Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial by Murtola, T J, Tammela, T L J, Määttänen, L, Ala-opas, M, Stenman, U H, Auvinen, A

“…Background: The Prostate Cancer Prevention Trial has shown a protective effect of finasteride on prostate cancer in low-risk men. It is uncertain whether…”
Get full text

A randomized trial of choice of treatment in prostate cancer: the effect of intervention on the treatment chosen by Auvinen, A., Hakama, M., Ala‐Opas, M., Vornanen, T., Leppilahti, M., Salminen, P., Tammela, T.L.J.

“…OBJECTIVE To determine whether different approaches in the choice of treatment affect the treatment chosen by the patient for prostate cancer. PATIENTS AND…”
Get full text

Prognostic value and expression of p21(waf1/cip1) protein in prostate cancer by Aaltomaa, S., Lipponen, P., Eskelinen, M., Ala-Opas, M., Kosma, V.M.

“…BACKGROUND p21(waf1/cip1) protein is a cyclin‐dependent kinase inhibitor able to arrest the cell cycle at the G1 phase by inhibiting DNA replication. The…”
Get full text

Expression and prognostic value of CD44 standard and variant v3 and v6 isoforms in prostate cancer by Aaltomaa, S, Lipponen, P, Ala-Opas, M, Kosma, V M

“…The adhesion molecule CD44 standard (CD44s), and its variant isoforms v3 and v6 are associated with cell-to-cell adhesion. The down-regulation of CD44 standard…”
Get more information

Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-up by Lipponen, P., Aaltoma, S., Kosma, V.-M., Ala-Opas, M., Eskelinen, M.

“…The expression of the standard CD44 (CD44s) and its v6 isoform (CD44v6) was analysed immunohistochemically in 173 cases of transitional cell bladder cancer…”
Get full text

A randomized trial of the choice of treatment in prostate cancer: design and baseline characteristics by Auvinen, A., Vornanen, T., Tammela, T.L.J., Ala‐Opas, M., Leppilahti, M., Salminen, P., Hakama, M.

“…Objective To assess the effects of different approaches to decision‐making on the treatment chosen for prostate cancer and on the patients' quality of life in…”
Get full text

The prognostic value of inducible nitric oxide synthase in local prostate cancer by Aaltomaa, S.H., Lipponen, P.K., Viitanen, J., Kankkunen, J‐P., Ala‐Opas, M.Y., Kosma, V.‐M.

“…Objective To compare the clinical and histological data from patients with prostate cancer with the results of the immunohistochemical analysis of inducible…”
Get full text

The effect of photodynamic therapy on rat urinary bladder with orthotopic urothelial carcinoma by Grönlund‐Pakkanen, S., Wahlfors, J., Talja, M., Kosma, V.‐M., Pakkanen, T.M., Ala‐Opas, M., Alhava, E., Moore, R.B.

“…OBJECTIVE To assess the effect of whole‐bladder photodynamic therapy (PDT) on a rat model with orthotopic superficial bladder cancer, as PDT is an alternative…”
Get full text

False-positive screening results in the Finnish prostate cancer screening trial by Kilpeläinen, T P, Tammela, T L J, Määttänen, L, Kujala, P, Stenman, U-H, Ala-Opas, M, Murtola, T J, Auvinen, A

“…Background: There is evidence that prostate cancer (PC) screening with prostate-specific antigen (PSA) serum test decreases PC mortality, but screening has…”
Get full text

Expression of activator protein 2 in prostate cancer is related to tumor differentiation and cell proliferation by Lipponen, P, Aaltomaa, S, Kellokoski, J, Ala-Opas, M, Kosma, V

“…Activator protein 2 (AP-2) is a DNA-binding transcription factor that can activate the expression of p21 (waf1/cip1), which in turn causes growth arrest of…”
Get more information

Value of Ki-67 immunolabelling as a prognostic factor in prostate cancer by Aaltomaa, S, Lipponen, P, Vesalainen, S, Ala-Opas, M, Eskelinen, M, Syrjänen, K

“…The aim of the study was to analyze the results of Ki-67 immunostaining in prostatic adenocarcinoma and to assess its prognostic value. Clinical follow-up data…”
Get more information

The morphological changes in rat bladder after photodynamic therapy with 5‐aminolaevulinic acid‐induced protoporphyrin IX by Grönlund‐pakkanen, S., Pakkanen, T.M., Talja, M., Kosma, V.‐M., Ala‐opas, M., Alhava, E.

“…Objective To assess the optimum light energy needed to induce only superficial bladder wall damage during photodynamic therapy (PDT) as a treatment for bladder…”
Get full text

MR Urography in Evaluation of Acute Flank Pain: T2-Weighted Sequences and Gadolinium-Enhanced Three-Dimensional FLASH Compared with Urography by Sudah, M, Vanninen, R, Partanen, K, Heino, A, Vainio, P, Ala-Opas, M

Get full text

Bladder management in persons with spinal cord lesion by DAHLBERG, A, PERTTILÄ, I, WUOKKO, E, ALA-OPAS, M

“…Cross-sectional clinical descriptive prevalence study. To evaluate the methods of self-reported bladder management, the frequency of urinary tract infection…”
Get full text

Expression of cyclins A and D and p21 proteins in renal cell cancer and their relation to clinicopathological variables and patient survival by AALTOMAA, S, LIPPONEN, P, ALA-OPAS, M, ESKELINEN, M, SYRJÄNEN, K, KOSMA, V.-M

“…We have studied 118 renal cell carcinomas to analyse the expressions of cyclins A and D1 and p21(waf1/cip1), and their relationship to clinical and…”
Get full text

Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial by MÄÄTTÄNEN, L, HAKAMA, M, TAMMELA, T. L. J, RUUTU, M, ALA-OPAS, M, JUUSELA, H, MARTIKAINEN, P, STENMAN, U.-H, AUVINEN, A

“…Specificity constitutes a component of validity for a screening test. The number of false-positive (FP) results has been regarded as one of major shortcomings…”
Get full text

The Finnish trial of prostate cancer screening: where are we now? by Finne, P., Stenman, U.‐H., Määttänen, L., Mäkinen, T., Tammela, T.L.J., Martikainen, P., Ruutu, M., Ala‐Opas, M., Aro, J., Karhunen, P.J., Lahtela, J., Rissanen, P., Juusela, H., Hakama, M., Auvinen, A.

Get full text

α-Catenin expression has prognostic value in local and locally advanced prostate cancer by AALTOMAA, S, LIPPONEN, P, ALA-OPAS, M, ESKELINEN, M, KOSMA, V. M

“…Normally functioning cell-cell adhesion plays an important role in the maintenance of tissue architecture and cell cohesion. E-cadherin is an important…”
Get full text

Human complement factor H related protein test for monitoring bladder cancer by Raitanen, M P, Marttila, T, Nurmi, M, Ala-Opas, M, Nieminen, P, Aine, R, Tammela, T L

“…The BTA stat test is a rapid, noninvasive, qualitative urine test that detects bladder tumor associated antigen (human complement factor H related protein) in…”
Get more information

Prognostic value of Ki-67 expression in renal cell carcinomas by Aaltomaa, S, Lipponen, P, Ala-Opas, M, Eskelinen, M, Syrjänen, K

“…The aim of the study was to determine the prognostic power of Ki-67 immunostaining in renal cell carcinomas (RCC). Clinical follow-up data were reviewed in 111…”
Get more information